Lupin Somerset production plant gets EIR from USFDA

Lupin Somerset production plant gets EIR from USFDA

by admin- Thursday, July 7th, 2022 03:54:45 PM

Global pharma most important Lupin obtained the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Somerset, NJ manufacturing facility, after the inspection of the power in March 2022. The US FDA has determined that the inspection classification of the power is Voluntary Action Indicated (VAI).

News Updates